STRS Ohio’s Viking Therapeutics VKTX Stock Holding History

STRS Ohio’s Portfolio VKTX Stock Details VKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$109K	Buy	2,800 +194	+7%	+$6.27K	﹤0.01%	1845
2026 Q1	$84.8K	Sell	2,606 -4	-0.2%	-$129	﹤0.01%	1824
2025 Q4	$91.8K	Buy	2,610 +5	+0.2%	+$177	﹤0.01%	1839
2025 Q3	$68.5K	Buy	2,605 +1	+0%	+$30	﹤0.01%	1935
2025 Q2	$69K	Sell	2,604 -22,396	-90%	-$590K	﹤0.01%	1963
2025 Q1	$604K	Sell	25,000 -22,286	-47%	-$704K	﹤0.01%	1068
2024 Q4	$1.9M	Sell	47,286 -16,836	-26%	-$960K	0.01%	654
2024 Q3	$4.06M	Buy	64,122 +11,509	+22%	+$675K	0.02%	507
2024 Q2	$2.79M	Buy	52,613 +40,113	+321%	+$2.63M	0.01%	529
2024 Q1	$1.02M	Buy	+12,500	New	+$556K	﹤0.01%	904
2023 Q4	–	Sell	-8,700	Closed	-$96K	–	2018
2023 Q3	$96K	Sell	8,700 -19,500	-69%	-$279K	﹤0.01%	1720
2023 Q2	$457K	Buy	+28,200	New	+$591K	﹤0.01%	1317
2018 Q3	–	Sell	-12,700	Closed	-$151K	–	2185
2018 Q2	$120K	Buy	+12,700	New	+$84.5K	﹤0.01%	1828

Other funds holding VKTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

STRS Ohio's VKTX Position: Q2 2026 in Review

STRS Ohio increased its Viking Therapeutics (VKTX) stake by 7.4% in Q2 2026, buying an estimated $6.27K and bringing the position to 2,800 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #1845.

STRS Ohio first reported a position in VKTX in Q2 2018 and has held it in 13 quarters since. The position peaked at $4.06M in Q3 2024. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

STRS Ohio held 2,800 shares of Viking Therapeutics worth $109K as of Q2 2026.
STRS Ohio bought 194 Viking Therapeutics shares in Q2 2026, an estimated $6.27K.
Viking Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #1845 holding.
STRS Ohio first reported a position in Viking Therapeutics in Q2 2018 and has held it in 13 quarters since.
STRS Ohio's Viking Therapeutics position peaked at $4.06M in Q3 2024.
436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.